GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (NSE:METROPOLIS) » Definitions » Return-on-Tangible-Asset

Metropolis Healthcare (NSE:METROPOLIS) Return-on-Tangible-Asset : 14.93% (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Metropolis Healthcare's annualized Net Income for the quarter that ended in Mar. 2025 was ₹1,166 Mil. Metropolis Healthcare's average total tangible assets for the quarter that ended in Mar. 2025 was ₹7,809 Mil. Therefore, Metropolis Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was 14.93%.

The historical rank and industry rank for Metropolis Healthcare's Return-on-Tangible-Asset or its related term are showing as below:

NSE:METROPOLIS' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 18.44   Med: 23.84   Max: 27.12
Current: 19

During the past 10 years, Metropolis Healthcare's highest Return-on-Tangible-Asset was 27.12%. The lowest was 18.44%. And the median was 23.84%.

NSE:METROPOLIS's Return-on-Tangible-Asset is ranked better than
94.57% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -4.41 vs NSE:METROPOLIS: 19.00

Metropolis Healthcare Return-on-Tangible-Asset Historical Data

The historical data trend for Metropolis Healthcare's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare Return-on-Tangible-Asset Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.20 26.88 20.61 18.44 19.39

Metropolis Healthcare Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.40 21.26 23.43 15.79 14.93

Competitive Comparison of Metropolis Healthcare's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Metropolis Healthcare's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metropolis Healthcare's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's Return-on-Tangible-Asset falls into.


;
;

Metropolis Healthcare Return-on-Tangible-Asset Calculation

Metropolis Healthcare's annualized Return-on-Tangible-Asset for the fiscal year that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=1449.683/( (7140.344+7808.94)/ 2 )
=1449.683/7474.642
=19.39 %

Metropolis Healthcare's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=1165.668/( (0+7808.94)/ 1 )
=1165.668/7808.94
=14.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Metropolis Healthcare  (NSE:METROPOLIS) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Metropolis Healthcare Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Metropolis Healthcare Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines